GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cogstate Ltd (ASX:CGS) » Definitions » Effective Interest Rate on Debt %

Cogstate (ASX:CGS) Effective Interest Rate on Debt % : 5.81% (As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cogstate Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Cogstate's annualized positive value of Interest Expense for the quarter that ended in Jun. 2024 was A$0.05 Mil. Cogstate's average total debt for the quarter that ended in Jun. 2024 was A$0.90 Mil. Therefore, Cogstate's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2024 was 5.81%.


Cogstate Effective Interest Rate on Debt % Historical Data

The historical data trend for Cogstate's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cogstate Effective Interest Rate on Debt % Chart

Cogstate Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.52 2.42 5.84 8.09 9.77

Cogstate Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.15 6.97 9.26 15.21 5.81

Competitive Comparison of Cogstate's Effective Interest Rate on Debt %

For the Health Information Services subindustry, Cogstate's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cogstate's Effective Interest Rate on Debt % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cogstate's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Cogstate's Effective Interest Rate on Debt % falls into.



Cogstate Effective Interest Rate on Debt % Calculation

Cogstate's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Jun. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Jun. 2023 )+Total Debt  (A: Jun. 2024 ))/ count )
=-1  *  -0.077/( (0.564+1.013)/ 2 )
=-1  *  -0.077/0.7885
=9.77 %

where

Total Debt  (A: Jun. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.04 + 0.524
=0.564

Total Debt  (A: Jun. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.685 + 0.328
=1.013

Cogstate's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2023 )+Total Debt  (Q: Jun. 2024 ))/ count )
=-1  *  -0.052/( (0.777+1.013)/ 2 )
=-1  *  -0.052/0.895
=5.81 %

where

Total Debt  (Q: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.003 + 0.774
=0.777

Total Debt  (Q: Jun. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.685 + 0.328
=1.013

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Jun. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Cogstate  (ASX:CGS) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Cogstate Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Cogstate's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cogstate Business Description

Traded in Other Exchanges
Address
161 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cogstate Ltd is a cognitive science company. The principal activity of the group is Creation, validation and commercialisation of digital brain health assessments; and Design and provision of quality assurance services in clinical trials, focused on the administration, scoring and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.

Cogstate Headlines

No Headlines